Skip to main content


Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!

Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!

  • Tuesday, April 16, 2024
  • 8:30 AM – 9:45 AM CT
    (3) Non-alcoholic Steatohepatitis (NASH) Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Voice
  • 8:30 AM – 9:45 AM CT
    (4) Federal Legislative and Regulatory Update
  • 8:30 AM – 9:45 AM CT
    (5) A Muti-Channel Approach Leveraging the Pharmacy Team to Resolving SDOH Barriers
  • 8:30 AM – 9:45 AM CT
    (6) 5.0… and Beyond! The Evolution of the AMCP Format Dossier
  • 8:30 AM – 9:45 AM CT
    (7) Beyond the Basics: Exploring the Intricacies of Medicare
  • 10:15 AM – 11:30 AM CT
    Health Care Reform and the Impact of PBM Legislation
  • 10:15 AM – 11:30 AM CT
    Spotlight 75 Session- Type 1 Diabetes: A Common and Progressive Autoimmune Disease
  • 10:15 AM – 11:30 AM CT
    (8) Navigating the Intersection of Managed Care Pharmacy and Patient Engagement
  • 10:15 AM – 11:30 AM CT
    (9) Blue Genes: Establishment of a pharmacogenomics testing program to broadly address mental health outcomes
  • 10:15 AM – 11:30 AM CT
    (10) Taming Million Dollar Drugs – A Healthcare System Emerging Therapies Program
  • 3:15 PM – 4:30 PM CT
    (11) Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology
  • 3:15 PM – 4:30 PM CT
    (12) (Un)Conscious Bias: Understanding What You Can(not) See
  • 3:15 PM – 4:30 PM CT
    (13) Rapid Health System Change, Implications to Pharmacy, and Actuarial Management of Uncertainty
  • 3:15 PM – 4:30 PM CT
    (14) Research Podium Session – Leveraging Real-World Data to Advance Managed Care Pharmacy Practice
  • 3:15 PM – 4:30 PM CT
    (15) You Can Round That! Establishing and Managing Mandatory Drug Wastage Programs